양전자방출단층촬영(PET) 세계 시장 규모는 2022년 23억 5,000만 달러로 평가되었으며, 2023년 25억 2,000만 달러에서 2031년에는 42억 1,000만 달러로 성장해 예측기간(2024-2031년)의 CAGR은 6.61%로 성장할 전망입니다.
암과 알츠하이머 병과 같은 생명을 위협하는 병리학의 유병률의 상승은 진단과 지속적인 환자 관리를 돕는 고급 이미징 기술에 필수적인 PET 스캔 수요를 크게 촉진하고 있습니다. 스캔은 신체의 생리적 및 대사적 과정에 대한 중요한 통찰력을 제공하며 건강 관리 전문가가 만성질환을 효과적으로 평가·관리하는 것을 가능하게 하고, 궁극적으로는 환자의 결과와 치료의 성공을 향상시킵니다. PET 검사는 환자 고유의 요구에 맞는 치료를 수행하는 데 매우 가치가 있습니다. 이러한 이미지 기술은 분자 이미징 기술의 진보와 스캔의 정밀도와 효율을 높이는 인공지능(AI)과 머신러닝의 도입으로 질병의 진행과 치료 반응을 정확하게 측정할 수 있도록 진화해 왔습니다. 이러한 기술 진화는 병리학의 더 나은 식별과 후속 조치를 용이하게 할뿐만 아니라, 다양한 의료 전문 분야에 걸친 연구와 임상 진단 모두에서 PET 스캔의 역할을 확대합니다. 더 개인화된 의료 접근에 대한 추진력을 반영합니다.
Global Positron Emission Tomography Market size was valued at USD 2.35 billion in 2022 and is poised to grow from USD 2.52 billion in 2023 to USD 4.21 billion by 2031, growing at a CAGR of 6.61% during the forecast period (2024-2031).
The rising prevalence of life-threatening conditions like cancer and Alzheimer's disease has significantly fueled the demand for PET scans, which are essential for advanced imaging technologies that aid in diagnosis and ongoing patient care. These scans provide crucial insights into the physiological and metabolic processes within the body, enabling healthcare professionals to effectively assess and manage chronic conditions, ultimately improving patient outcomes and treatment success. As chronic illnesses continue to rise, there is an increasing need for targeted therapeutics and personalized medicine, making PET scans invaluable for tailoring treatments to unique patient needs. These imaging techniques have evolved to measure disease progression and therapeutic responses accurately, thanks to advancements in molecular imaging technology and the incorporation of artificial intelligence (AI) and machine learning, which enhance the precision and efficiency of scans. This technological evolution not only facilitates better identification and follow-up of medical conditions but also expands the role of PET scans in both research and clinical diagnostics across various medical specialties. Consequently, the market for PET scans is experiencing robust growth, reflecting their integral role in contemporary healthcare and the drive towards more personalized medical approaches.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Positron Emission Tomography Market Segmental Analysis
Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Positron Emission Tomography Market
The escalating incidence of chronic diseases, including cancer, Alzheimer's disease, and cardiovascular disorders, serves as a pivotal market driver for the Global Positron Emission Tomography (PET) market. As these conditions necessitate sophisticated imaging techniques for effective diagnosis and ongoing management, PET scans have become vital tools in the healthcare arsenal. They provide critical insights into metabolic and physiological functions, which are essential for formulating tailored treatment plans. The burgeoning patient population suffering from chronic illnesses worldwide enhances the demand for PET technology, thereby propelling market growth. This trend underscores the need for advanced diagnostic modalities to effectively navigate the complexities of chronic disease management.
Restraints in the Global Positron Emission Tomography Market
The Global Positron Emission Tomography (PET) market faces significant restraints primarily due to the prohibitive costs associated with PET scanners. High purchase prices, coupled with substantial operational and maintenance expenses, pose hurdles for smaller medical facilities and diagnostic laboratories with limited budgets. This financial barrier restricts access to advanced imaging technologies, particularly in resource-constrained environments. As a result, the high costs hinder broader adoption and utilization of PET scanning services, ultimately stifling market growth and limiting the expansion of innovative applications that could enhance diagnostic capabilities and improve patient outcomes in the healthcare sector.
Market Trends of the Global Positron Emission Tomography Market
The Global Positron Emission Tomography (PET) market is experiencing significant growth driven by the integration of machine learning and artificial intelligence into scanning technologies. These advancements enhance image capture, reconstruction, and analysis, leading to improved diagnostic accuracy and expedited procedures. AI algorithms facilitate the detection of subtle anomalies and ensure precise tumor characterization, which translates into faster and more effective patient care. Furthermore, the utilization of machine learning to predict patient outcomes facilitates personalized treatment plans based on imaging data. As these technologies evolve, their incorporation into PET systems is poised to transform clinical and research practices, driving market expansion and accessibility.